Skip to main content
SpringerLink
Log in

Preparation of Polysaccharide-Conjugate Vaccines

  • Protocol
Vaccine Protocols

Part of the book series: Methods in Molecular Medicine™ ((MIMM,volume 87))

Abstract

It was recognized early last century that small molecules, known as haptens, can be made immunogenic after conjugation to carrier proteins (1). This principle has since been applied successfully to improve the immunogenicity of (poly)saccharides (2,3). We now know that the carrier proteins ensure the involvement of T-helper lymphocytes in the activation of the hapten- or polysaccharide-specific antibody-producing B lymphocytes (Fig. 1). In contrast to small molecules or haptens, polysaccharides (or other macromolecules with a repeating structure) are able to induce an immune response, most likely by directly activating B-lymphocytes. Antigens that are able to induce an immune response without the involvement of T-helper lymphocytes are referred to as TI (thymus-independent) antigens (4) (Table 1). TI-2 antigens, such as plain polysaccharides, are not able to activate relatively immature B-cells. This is in contrast to TI-l antigens, which can activate immature B-cells because of their mitogenic activity. Lipopolysaccharides (LPS) are examples of TI-l antigens. Conventional T-cells recognize peptide sequences in association with the major histocompatibility complex (MHC). Recently, unconventional T-cells were found to recognize (glyco) lipids in a CD1-restricted way, γδT-cells were shown to respond to non-proteinaceous microbial ligands (that may include carbohydrates) in a virtually MHC-unrestricted way (5). The findings of T-cell regulation of the immune response against polysaccharides (6–8) without biochemical demonstration of the specificity of the molecular interactions can best be explained by assuming a role for anti-idiotypic antibodies and T-cells specific for the idiotopes (carbohydrate mimotopes) or via the newly discovered unconventional T-cells.

Polysaccharides are poor in activating B-cells to the production of antibodies in children younger than 2 yr of age. If antibodies are formed, they are of short duration. For conjugate vaccines T-cells are involved in the activation of B-cells. Presumably, the conjugate is taken up by polysaccharide-specific B-cells, processed, and presented to carrier-specific T-cells. The involvement of T-cells results in the activation of B-cells to production of antibodies and induction of memory in children younger than 2 yr of age.

Table 1 Characteristics of T-Cell Independent Antigens
Full size table

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Landsteiner, K. and Van der Scheer, J. (1929) Serological differentiation of steric isomers (antigens containing tartaric acids). J. Exp. Med. 50, 407–417.

    Article  PubMed  CAS  Google Scholar 

  2. Avery, O. T. and Goebel, W. F. (1931) Chemo-immunological studies on conjugated carbohydrate-proteins. V. The immunological specificity of an antigen pre-pared by combining the capsular polysaccharide of type III Pneumococcus with foreign protein. J. Exp. Med. 54, 437–447.

    Article  PubMed  CAS  Google Scholar 

  3. Goebel, W. F. and Avery, O. T. (1931) Chemo-immunological studies on conjugated carbohydrate-proteins. IV. The synthesis of the p-aminobenzyl ether of the soluble specific substance of type III Pneumococcus and its coupling with protein. J. Exp. Med. 54, 431–436.

    Article  PubMed  CAS  Google Scholar 

  4. Mosier, D. E., Zaldivar, N. M., Goldings, E., Mond, J., Scher, I., and Paul, W. E. (1977) Formation of antibody in the newborn mouse: study of T-cell-independent antibody response. J. Infect. Dis. 136, S14–S19.

    PubMed  Google Scholar 

  5. Kaufmann, S. H. E. and Reimann, J. (1999) Immunology of infection, in: Methods in Microbiology (Perlmann, P. and Wigzell, H., eds.), Springer, New York, pp. 21–42.

    Google Scholar 

  6. Baker, P. J., Stashak, P. W., Amsbaugh, D. F., Prescott, B., and Barth, R. F. (1970) Evidence for the existence of two functionally distinct types of cells which regulate the antibody response to type 3 pneumococcal polysaccharide. J. Immunol. 105, 1581–1583.

    PubMed  CAS  Google Scholar 

  7. Baker, P. J., Reed, N. D., Stashak, P. W., Amsbaugh, D. F., and Prescott, B. (1973) Regulation of the antibody response to type 3 pneumococcal polysaccharide. I. Nature of regulatory cells. J. Exp. Med. 137, 1431–1441.

    Article  PubMed  CAS  Google Scholar 

  8. Braley-Mullen, H. (1974) Regulatory role of T-cells in IgG antibody formation and immune memory to type III pneumococcal polysaccharide. J. Immunol. 113, 1909–1920.

    PubMed  CAS  Google Scholar 

  9. Kayhty, H., Karanko, V., Peltola, H., and Makela, P. H. (1984) Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory. Pediatrics 74, 857–865.

    PubMed  CAS  Google Scholar 

  10. Peltola, H., Kayhty, H., Sivonen, A., and Makela, P. H. (1977) Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Pediatrics 60, 730–737.

    PubMed  CAS  Google Scholar 

  11. Baker, P. J., Amsbaugh, D. F., Stashak, P. W., Calder, G., and Prescott, B. (1981) Regulation of the antibody response to pneumococcal polysaccharide by thymus-derived cells. Rev. Infect. Dis. 3, 332–341.

    Article  PubMed  CAS  Google Scholar 

  12. Eskola, J., Kayhty, H., Takala, A. K., Peltola, H., Ronnberg, P.-R., Kela, E., et al. (1990) A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. N. Engl. J. Med. 323, 1381–1387.

    Article  PubMed  CAS  Google Scholar 

  13. Santosham, M., Wolff, M., Reid, R., Hohenboken, M., Bateman, M., Goepp, J., et al. (1991) The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influelizae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. N. Engl. J. Med. 324, 1767–1772.

    Article  PubMed  CAS  Google Scholar 

  14. Black, S. B., Shinefield, H. R., Fireman, B., Hiatt, R., Polen, M., Vittinghoff, E., and The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group (1991) Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. Pediatr. Infect. Dis. J. 10, 97–104.

    Article  PubMed  CAS  Google Scholar 

  15. Wenger J. D., Heath, P. T., Moxon, R., and Booy, R. (1997) Epidemiological impact of conjugate vaccines against invasive disease caused by H. influenzae type b, in New Generation Vaccines 2nd ed. (Levine, M. M., Woodrow, G. C., Kaper, J. B., and Cobon, G. S., eds.), Marcel Dekker, NY, pp. 489–502.

    Google Scholar 

  16. Maclennan, J. M., Shackley, F., Heath, P. T., Deeks, J. J., Flamark, C., Herbert, M., et al. (2000) Safety, immunogenicity and induction of immunological memory by a serogroup C meningococcal conjugate vaccine in infants; a randomised controlled trial. J. Am. Med. Assoc. 283, 2795–2801.

    Article  CAS  Google Scholar 

  17. Ramsey, M. E., Andrews, N., Kaczmarski, E. B., and Miller, E. (2001) Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet 357, 195–196.

    Article  Google Scholar 

  18. Miller, E., Salisbury, D., and Ramsey, R. (2001) Planning, registration and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story. Vaccine 20, S58–S67.

    Article  PubMed  Google Scholar 

  19. Black S., Shinefield, H., Fireman B., Lewis, E., Ray, P., Hansen, J.R., and the Northern California Kaiser Permanents Vaccine Study Center Group. (2000) Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr. Infect. Dis. J. 19, 187–195.

    Article  PubMed  CAS  Google Scholar 

  20. de Weers, O, Beurret M., van Buren L., Oomen L. A., Poolman J. T., and Hoogerhout P. (1998). Application of cystamine and N,N’-bis(glycyl)cystamine as linkers in polysac-charide-protein conjugation. Bioconjugate Chem. 9, 309–315.

    Article  Google Scholar 

  21. Alonso de Velasco, E., Verheul, A. F. M., Veeneman, G. H., Gomes, L. J. F., van Boom, J, H., et al. (1993) Protein-conjugated synthetic disaccharide and trisaccharide of pneumococcal type 17F exhibit a different immunogenicity and antigenicity than tetrasaccharide. Vaccine 11, 1429–1436.

    Article  PubMed  CAS  Google Scholar 

  22. Anderson, P. W. and Insel, R. A. (1988) Prospects for overcoming maturational and genetic barriers to the human antibody response to the capsular polysaccharide of Haemophilus influenzae type b. Vaccine 6, 188–191.

    Article  PubMed  CAS  Google Scholar 

  23. Bundle, D. R. (1979) Antibody to an artificial disaccharide antigen cross-reactive with Neisseria gonorrhoeae lipopolysaccharide. Can. J. Biochem. 57, 367–371.

    Article  PubMed  CAS  Google Scholar 

  24. Dick, W. E., Jr. and Beurret, M. (1989) Glycoconjugates of bacterial carbohydrate antigens. A survey and consideration of design and preparation factors, in Contributions to Microbiology and Immunology, vol. I0. Conjugate Vaccines (Cruse, J. M. and Lewis, R. E., Jr., eds.), Kruger, Basel, pp. 48–114.

    Google Scholar 

  25. Stein, K. E. (1994) Glycoconjugate vaccines. What next? Int. J. Technic. Assess. Health Care 10, 167–176.

    Article  CAS  Google Scholar 

  26. Szu, S. C., Bystricky, S., Hinojosa-Ahumada, M., Egan, W., and Robbins, J. B. (1994) Synthesis and some immunologic properties of an O-acetyl pectin [poly (1→4)-α-D-GalpA]-protein conjugate as a vaccine for typhoid fever. Infect. Immun. 62, 5545–5549.

    PubMed  CAS  Google Scholar 

  27. Verheul, A. F. M., Braat, A. K., Leenhouts, J. M., Hoogerhout, P., Poolman, J. T., Snippe, H., et al. (1991) Preparation, characterization, and immunogenicity of meningococcal immunotype L2 and L3,7,9 phosphoethanolamine group-containing oligosaccharide-protein conjugates. Infect. Immun. 59, 843–851.

    PubMed  CAS  Google Scholar 

  28. Jann, K. and Westphal, O. (1975) Microbial polysaccharides, in The Antigens, vol. 3. (Sela, M., ed.), Academic Press, New York, pp. 1–125.

    Google Scholar 

  29. Jennings, H. J. (1983) Capsular polysaccharides as human vaccines. Adv. Carbohydr. Chem. Biochem. 41, 155–208.

    Article  PubMed  CAS  Google Scholar 

  30. Kenne, L. and Lindberg, B. (1983) Bacterial polysaccharides, in The Polysaccharides, vol. 2. (Aspinall, G. O., ed.), Academic Press, Orlando, FL, pp. 287–363.

    Google Scholar 

  31. Jennings, H. J. (1990) Capsular polysaccharides as vaccine candidates, in Current Topics in Microbiology and Immunology, vol. 150. Bacterial Capsules (Jann, K. and Jann, B., eds.), Springer-Verlag, Berlin, pp. 97–127.

    Google Scholar 

  32. Knirel’, Y. A. and Kochetkov, N. K. (1993) The structure of lipopolysaccharides of gram-negative bacteria. II. The structure of the core region (a review). Biokhimiya 58, 84–99.

    Google Scholar 

  33. Lee, C.-J. (1987) Bacterial capsular polysaccharides-biochemistry, immunity and vaccine. Mol. Immunol. 24, 1005–1019.

    Article  PubMed  CAS  Google Scholar 

  34. Luderitz, O., Freudenberg, M. A., Galanos, C:, Lehmann, V., Rietschel, E. T., and Shaw, D. H. (1982) Lipopolysaccharides of gram-negative bacteria. Curr. Top. Membranes Transp. 17, 79–151.

    Google Scholar 

  35. Geyer, H., Stirm, S., and Himmelspach, K. (1979) Immunochemical properties of oligosaccharide-protein conjugates with Klebsiella-K2 specificity. I. Specificity and crossreactivity of anti-conjugate versus anti-bacterial antibodies. Med. Microbial. Immunol. (Beril.) 165, 271–288.

    Article  CAS  Google Scholar 

  36. Jaton, J. C., Huser, H., Braun, D. G., Givol, D., Pecht, I., and Schlessinger, J. (1975) Conformational changes induced in a homogeneous anti-type III pneumococcal antibody by oligosaccharides of increasing size. Biochemistry 14, 5312–5315.

    Article  PubMed  CAS  Google Scholar 

  37. Kabat, E. A. and Bezer, A. E. (1958) The effect of variation in molecular weight on the antigenicity of dextran in man. Arch. Biochem. Biophys. 78, 306–318.

    Article  PubMed  CAS  Google Scholar 

  38. Maeda, H., Schmidt, K. A., Engel, J., and Jaton, J. C. (1977) Kinetics of binding of oligosaccharides to a homogeneous pneumococcal antibody: dependence on antigen chain length suggests a labile intermediate complex. Biochemistry 16, 4086–4089.

    Article  PubMed  CAS  Google Scholar 

  39. Makela, O., Peterfy, F., Outschoorn, I. G., Richter, A. W., and Seppala, I. (1984) Immunogenic properties of α(1→6) dextran, its protein conjugates, and conjugates of its breakdown products in mice. Scand. J. Immunol. 19, 541–550.

    Article  PubMed  CAS  Google Scholar 

  40. Peeters, C. C. A. M., Evenberg, D., Hoogerhout, P., Kayhty, H., Saarinen, L., van Boeckel, C. A. A., et al. (1992) Synthetic trimer and tetramer of 3-β-d-ribose-(1-1)-D-ribitol-5-phosphate conjugated to protein induce antibody responses to Haemophilus influenzae type b capsular polysaccharide in mice and monkeys. Infect. Immun. 60, 1826–1833.

    PubMed  CAS  Google Scholar 

  41. Seppala, I. and Makela, O. (1989) Antigenicity of dextran-protein conjugates in mice. Effect of molecular weight of the carbohydrate and comparison of two modes of coupling. J. Immunol. 143, 1259–1264.

    PubMed  CAS  Google Scholar 

  42. Pozsgay, V. (2000) Oligosaccharide-protein conjugates as vaccine candidates against bacteria. Advances in Carbohydrate Chemistry and Biochemistry 56, 153–199.

    Article  PubMed  CAS  Google Scholar 

  43. Jennings, H. J., Roy, R., and Michon, F. (1985) Determinant specificities of the group B and C polysaccharides of Neisseria meningitidis. J. Immunol. 134, 2651–2657.

    PubMed  CAS  Google Scholar 

  44. Lifely, M. R., Mareno, C., and Lindon, J. C. (1987) An integrated molecular and immunological approach towards a meningococcal group B vaccine. Vaccine 5, 11–26.

    Article  PubMed  CAS  Google Scholar 

  45. Richter, A. W. and Eby, R. (1985) Studies on artificial oligosaccharide-protein antigens: induction of precipitating antibodies to defined epitopes on natural and synthetic dextrans and mannans. Mol. Immunol. 22, 29–36.

    Article  PubMed  CAS  Google Scholar 

  46. Goebel, W. F. (1939) Studies on antibacterial immunity induced by artificial antigens. I. Immunity to experimental pneumococcal infection with an antigen containing cellobiuronic acid. J. Exp. Med. 69, 353–364.

    Article  PubMed  CAS  Google Scholar 

  47. Goebel, W. F. (1940) Studies on antibacterial immunity induced by artificial antigens. II. Immunity to experimental pneumococcal infection with antigens containing saccharides of synthetic origin. J. Exp. Med. 72, 33–48.

    Article  PubMed  CAS  Google Scholar 

  48. Makela, O., Mattila, P., Rautonen, N., Seppala, I., Eskola, J., and Kayhty, H. (1987) Isotype concentrations of human antibodies to Haemophilus influenzae type b polysaccharide (Hib) in young adults immunized with the polysaccharide as such or conjugated to a protein (diphtheria toxoid). J. Immunol. 139, 1999–2004.

    PubMed  CAS  Google Scholar 

  49. Lindberg, B., Lönngren, J., and Svensson, S. (1975) Specific degradation of polysaccharides. Adv. Carbohydr. Chem. Biochem. 31, 185–240.

    Article  CAS  Google Scholar 

  50. Pigman, W. W. and Wolfram, M. L., eds. (1945-1968) Advances in Carbohydrate Chemistry, vol. 1–23, Academic, Orlando, FL.

    Google Scholar 

  51. Whistler, R. L., Wolfram, M. L., Shafizadeh, F., and BeMiller, J. N., eds. (1962–1980) Methods in Carbohydrate Chemistry, vol. 1–8. Academic Press, Orlando, FL.

    Google Scholar 

  52. Wolfram, M. L., Tipson, R. S., and Horton, D., eds. (1969–1994) Advances in Carbohydrate Chemistry and Biochemistry, vol. 24–50. Academic Press, Orlando, FL.

    Google Scholar 

  53. Yalpani, M. (1985) A survey of recent advances in selective chemical and enzymic polysaccharide modifications. Tetrahedron 41, 2957–3020.

    Article  CAS  Google Scholar 

  54. Kubo, K., Nakamura, T., Takagaki, K., Yoshida, Y., and Endo, M. (1993) Depolymerization of hyaluronanby sonication. Glycoconjugate J. 10, 435–439.

    Article  CAS  Google Scholar 

  55. Szu, S. C., Zon, G., Schneerson, R., and Robbins, J. B. (1986) Ultrasonic irradiation of bacterial polysaccharides. Characterization of the depolymerized products and some applications of the process. Carbohydr. Res. 182, 7–20.

    Article  Google Scholar 

  56. Kniskern, P. J., Ip, C. C., Hagopian, A., Hennessey, J. P., Jr., Miller, W. J., Kubek, D. J., et al. (1992) Pneumococcal polysaccharide conjugate vaccine. Eur. Pat. Appl. 0 497 525 A2. Merck and Co., Inc., Rahway, N.J.

    Google Scholar 

  57. Baker, E. E. and Whiteside, R. E. (1965) Preparation and properties of a Vi antigen-degrading enzyme. J. Bacteriol. 89, 1217–1224.

    PubMed  CAS  Google Scholar 

  58. Dutton, G. G. S., Di Fabio, J. L., Leek, D. M., Merrifield, E. H., Nunn, J. R., and Stephen, A. M. (1981) Preparation of oligosaccharides by the action of bacteriophage-borne enzymic on Klebsiella capsular polysaccharides. Carbohydr. Res. 97, 127–138.

    Article  PubMed  CAS  Google Scholar 

  59. Geyer, H., Himmelspach, K., Kwiatkowski, B., Schlecht, S., and Stirm, S. (1983) Degradation of bacterial surface carbohydrates by virus-associated enzymes. Pure Appl. Chem. 55, 637–653.

    Article  CAS  Google Scholar 

  60. Kwiatkowski, B., Boschek, B., Thiele, H., and Stirm, S. (1983) Substrate specificity of two bacteriophage associated endo-N-acetylneuraminidases. J. Virol. 45, 367–374.

    PubMed  CAS  Google Scholar 

  61. Tomlinson, S. and Taylor, P. W. (1985) Neuraminidase associated with coliphage E that specifically depolymerizes the Escherichia coli KI capsular polysaccharide. J. Virol. 55, 374–378.

    PubMed  CAS  Google Scholar 

  62. Uchida, T., Pappenheimer, A. M., Jr., and Harper, A. A. (1972) Reconstitution of diphtheria toxin from two nontoxic cross-reacting mutant proteins. Science 175, 901–903.

    Article  PubMed  CAS  Google Scholar 

  63. Pappenheimer, A. M., Jr., Uchida, T., and Harper, A. A. (1972) An immunological study of the diphtheria toxin molecule. Immunochemistry 9, 891–906.

    Article  PubMed  CAS  Google Scholar 

  64. Barington, T., Skettrup, M., Juul, L., and Heilmann, C. (1993) Non—specific suppression of the antibody response to Haemophilus influenzae type b conjugate vaccines by preimmunization with vaccine components. Infect. Immun. 61, 432–438.

    PubMed  CAS  Google Scholar 

  65. Barington, T., Gyhrs, A., Kristensen, K., and Heilmann, C. (1994) Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine. Infect. Immun. 62, 9–14.

    PubMed  CAS  Google Scholar 

  66. Peeters, C. C. A. M., Tenbergen-Meekes, A.-M., Poolman, J. T., Beurret, M., Zegers, B. J. M., and Rijkers, G. T. (1991) Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines. Infect. Immun. 59, 3504–35 10.

    PubMed  CAS  Google Scholar 

  67. Dintzis, H. M. and Dintzis, R. Z. (1992) Profound specific suppression by antigen of persistent IgM, IgG, and IgE antibody production. Proc. Natl. Acad. Sci. USA 89, 1113–1117.

    Article  PubMed  CAS  Google Scholar 

  68. Fattom, A., Hee Cho, Y., Chu, C., Fuller, S., Fries, L., and Naso, R. (1991). Epitopic overload at the site of injection may result in supression of the immune response to combined capsular polysaccharide conjugate vaccines. Vaccine 17, 126–133.

    Google Scholar 

  69. Crowley-Luke, A., Reddin, K. M., Gorringe, A. R., Hudson, M. J., and Robinson, A. (2001) Formulation and characterisation of Bordetella pertussis fimbriae as novel carrier proteins for Hib conjugate vaccines. Vaccine 19, 3399–3407.

    Article  PubMed  CAS  Google Scholar 

  70. Reddin, K. M., Crowley-Luke, A., Clark, S. O., Vincent, P. J., Gorringe, A. R., Hudson, M. J., et al. Bordetella pertussis fimbriae are effective carrier proteins in Neisseria meningitidis serogroup C conjugate vaccines. FEMS Immunol. Med. Micro. 31, 153–162.

    Google Scholar 

  71. Paradiso, P. R., Dermody, K., and Pillai, S. (1993) Novel approaches to the development of glycoconjugate vaccines with synthetic peptides as carriers. Vacc. Res. 2, 239–248.

    CAS  Google Scholar 

  72. Bixler, G. S., Jr., Eby, R., Dermody, K. M., Woods, R. M., Seid, R. C., Jr., and Pillai, S. (1989) Synthetic peptide representing a T-cell epitope of CRM197 substitutes as carrier molecule in a Haemophilus influenzae type B (Hib) conjugate vaccine. Adv. Exp. Med. Biol. 251, 175–180.

    PubMed  CAS  Google Scholar 

  73. Lett, E., Gangloff, S., Zimmermann, M., Wachsmann, D., and Klein, J.-P. (1994) Immunogenicity of polysaccharides conjugated to peptides containing T-and B-cell epitopes. Infect. Immun. 62, 785–792.

    PubMed  CAS  Google Scholar 

  74. Aplin, J. D. and Wriston, J. C., Jr. (1981) Preparation, properties, and applications of carbohydrate conjugates of proteins and lipids. CRC Crit. Rev. Biochem. 10, 259–306.

    Article  PubMed  CAS  Google Scholar 

  75. Pazur, J. H. (1981) Affinity chromatography of macromolecular substances on adsorbents bearing carbohydrate ligands. Adv. Carbohydr. Chem. Biochem. 39, 405–447.

    Article  PubMed  CAS  Google Scholar 

  76. Porath, J. (1974) General methods and coupling procedures. Meth. Enzymol. 34B, 13–30.

    Article  Google Scholar 

  77. Stowell, C. P. and Lee, Y. C. (1980) Neoglycoproteins. The preparation and application of synthetic glycoproteins. Adv. Carbohydr. Chem. Biochem. 37, 225–281.

    Article  PubMed  CAS  Google Scholar 

  78. Wilchek, M., Miron, T., and Kohn, J. (1984) Affinity chromatography. Meth. Enzymol. 104C, 3–55.

    Article  Google Scholar 

  79. Hermanson, G.T. (1996). Bioconjugate Techniques. Academic Press, San Diego, CA.

    Google Scholar 

  80. Jennings, H.J. and Sood, R.K. 1994. Synthetic glycoconjugates as human vaccines. In Lee, Y.C. and Lee, R.T. (eds.), Neoglycoconjugates: Preparation and Applications (pp. 325–371). San Diego: Academic Press, Inc.

    Google Scholar 

  81. Kohn, J. and Wilchek, M. (1986) The use of cyanogen bromide and other novel cyanylating reagents for the activation of polysaccharide resins. Appl. Biochem. Biotechnol. 9, 285–305.

    Article  Google Scholar 

  82. Anderson, P. W., Pichichero, M. E., Insel, R. A., Betts, R., Eby, R., and Smith, D. H. (1986) Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenzae type b coupled to a protein carrier: structural and temporal requirements for priming in the human infant. J. Immunol. 137, 1181–1186.

    PubMed  CAS  Google Scholar 

  83. Beuvery, E. C., Roy, R., Kanhai, V., and Jennings, H. J. (1986) Characteristics of two types of meningococcal group C polysaccharide conjugates using tetanus toxoid as carrierprotein. Dev. Biol. Stand. 65, 197–204.

    PubMed  CAS  Google Scholar 

  84. Jennings, H. J. and Lugowski, C. (1981) Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates. J. Immunol. 127, 1011–1018.

    PubMed  CAS  Google Scholar 

  85. Beuvery, E. C., Miedema, F., van Delft, R., and Haverkamp, J. (1983) Preparation and immunochemical characterization of meningococcal group C polysaccharide-tetanus toxoid conjugates as a new generation of vaccines. Infect. Immun. 40, 39–45.

    PubMed  CAS  Google Scholar 

  86. Marburg, S., Jorn, D., Tolman, R. L., Arison, B., McCauley, J., Kniskem, P. J., et al. (1986) Bimolecular chemistry of macromolecules: synthesis of bacterial polysaccharide conjugates with Neisseria meningitidis membrane protein. J. Am. Chem. Soc. 108, 5282–5287.

    Article  CAS  Google Scholar 

  87. Shafer, D. E., Toll, B., Schuman, R. F., Nelson, B. L., Mond, J. J., and Lees, A. (2000) Activation of soluble polysaccharide with 1-cyano-4-dimethylaminopyridium tetrafluoro-borate (CDAP) for use in protein-polysaccharide conjugate vaccines and immunological reagents. II Selective cross-linking of proteins to CDAP-activated polysaccharides. Vaccine 18, 1273–1281.

    Article  PubMed  CAS  Google Scholar 

  88. Schneller, M. and Geiger, R.E. (1992) An effective method for the synthesis of neoglycoproteins and neogangliosideproteins by use of reductively aminated sulfhydryl-containing carbohydrate conjugates. Biol. Chem. Hoppe-Seyler 373, 1095–1104.

    PubMed  CAS  Google Scholar 

  89. Costantino, P., Viti, S., Vannozzi, F., Serafini G., Marsili, I., and Valeri, A. (1986) Immunochemistry of some bacterial oligosaccharide protein conjugates. Ann. Sclavo Collana Monogr. 3, 359–366.

    PubMed  CAS  Google Scholar 

  90. Cryz, S. J., Jr., Furer, E. P., Cross, A. S., Wegmann, A., Germanier R., and Sadoff, J. C. (1987) Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans. J. Clin. Investig. 80, 51–56.

    Article  PubMed  CAS  Google Scholar 

  91. Akerblom, E., Dohlsten, M., Bryno, C., Mastej, M., Steringer, I., Hedlund, G., et al. (1993) Preparation and characterization of conjugates of monoclonal antibodies and staphylococcus enterotoxin A using a new hydrophilic cross-linker. Bioconjugate Chem. 4, 455–466.

    Article  CAS  Google Scholar 

  92. Andersson, M., Oscarson, S., and Ohberg, L. (1993) Synthesis of oligosaccharides with oligoethylene glycol spacers and their conversion into glycoconjugates using N,N,N I N I-tetramethyl(succinimido)uronium tetrafluoroborate as coupling reagent. Glycoconjugate J. 10, 461–465.

    Article  CAS  Google Scholar 

  93. Collioud, A., Clemence, J. F., Sanger, M., and Sigrist, H. (1993) Oriented and covalent immobilization of target molecules to solid supports: synthesis and application of a lightactivatable and thiol-reactive cross-linking reagent. Bioconjugate Chem. 4, 528–536.

    Article  CAS  Google Scholar 

  94. Jennings, H. J. (1992) Further approaches for optimizing polysaccharide-protein conjugate vaccines for prevention of invasive bacterial disease. J. Infect. Dis. 165, S156–S159.

    PubMed  CAS  Google Scholar 

  95. Pozsgay, V. (1993) A method for glycoconjugate synthesis. Glycoconjugate J. 10, 133–141.

    Article  CAS  Google Scholar 

  96. Romanowska, A., Meunier, S. J., Tropper, F. D., Laferriere, C. A., and Roy, R. (1994) Michael additions for syntheses of neoglycoproteins. Meth. Enzymol. 242A, 90–101.

    Article  Google Scholar 

  97. Vilaseca, L. A., Rose, K., Werlen, R., Meunier, A., Offord, R. E., Nichols, C. L., et al. (1993) Protein conjugates of defined structure: synthesis and use of a new carrier molecule. Bioconjugate Chem. 4, 515–520.

    Article  CAS  Google Scholar 

  98. Yoshida, T. and Lee, Y. C. (1994) Glycamine formation via reductive amination of oligosaccharides with benzylamine: efficient coupling of oligosaccharides to protein. Carbohydr. Res. 251, 175–186.

    Article  PubMed  CAS  Google Scholar 

  99. Zara, J. J., Wood, R. D., Boon, P., Kim, C.-H., Pomato, N., Bredehorst, R., et al. (1991) A carbohydrate-directed heterobifunctional cross-linking reagent for the synthesis of immunoconjugates. Anal. Biochem. 194, 156–162.

    Article  PubMed  CAS  Google Scholar 

  100. Pawlowski, A., Källenius, G., and Svenson, S.B. (1999) A new method of non-cross-linking conjugation of polysaccharides to proteins via thioether bonds for the preparation of saccharide-protein conjugate vaccines. Vaccine 17, 1474–1483.

    Article  PubMed  CAS  Google Scholar 

  101. Pawlowski, A., Källenius, G., and Svenson, S.B. (2000) Preparation of pneumococcal capsular polysaccharide-protein conjugate vaccines utilizing new fragmentation and conjugation technologies. Vaccine 18, 1873–1885.

    Article  PubMed  CAS  Google Scholar 

  102. Beuvery, E. C., Van de Kaaden, A., Kanhai, V., and Leussink, A. B. (1983) Physicochemical and immunological characterization of meningococcal group A polysaccharide-tetanus toxoid conjugates prepared by two methods. Vaccine 1, 31–36.

    Article  PubMed  CAS  Google Scholar 

  103. Lepow, M. L., Samuelson, J. S., and Gordon, L. K. (1984) Safety and immunogenicity of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in adults. J. Infect. Dis. 150, 402–406.

    PubMed  CAS  Google Scholar 

  104. Schneerson, R., Robbins, J. E., Chu, C. Y., Sutton, A., Schiffman, G., and Vann, W. F. (1983) Semi-synthetic vaccines composed of capsular polysaccharides of pathogenic bacteria covalently bound to proteins for the prevention of invasive diseases. Prog. Allergy 33, 144–158.

    PubMed  CAS  Google Scholar 

  105. Braley-Mullen, H. (1980) Antigen requirements for priming of IgG producing B memory cells specific for Type III pneumococcal polysaccharide. Immunology 40, 521–527.

    PubMed  CAS  Google Scholar 

  106. Peeters, C. C. A. M., Tenbergen-Meekes, A.-M. J., Poolman, J. T., Zegers, B. J. M., and Rijkers, G T. (1992) Immunogenicity of a Streptococcus pneumoniae type 4 polysaccha-ride-protein conjugate vaccine is decreased by admixture of high doses of free saccharide. Vaccine 10, 833–840.

    Article  PubMed  CAS  Google Scholar 

  107. Wilson, D. and Braley-Mullen, H. (1981) Antigen requirements for priming of type III pneumococcal polysaccharide-specific IgG memory responses: suppression of memory with the T-independent form of antigen. Cell. Immunol. 64, 177–186.

    Article  PubMed  CAS  Google Scholar 

  108. Peeters, C. C. A. M., Tenbergen-Meekes, A.-M., Evenberg, D. E., Poolman, J. T., Zegers, B. J. M., and Rijkers, G. T. (1991) A comparative study of the immunogenicity of pneumococcal type 4 polysaccharide and oligosaccharide tetanus toxoid conjugates in adult mice. J. Immunol. 146, 4308–4314.

    PubMed  CAS  Google Scholar 

  109. Seid, R. C., Jr., Boykins, R. A., Liu, D.-F., Kimbrough, K. W., Hsieh, C.-L., and Eby, R. (1989) Chemical evidence for covalent linkages of a semi-synthetic glycoconjugate vaccine for Haemophilus influenzae type b disease. Glycoconjugate J. 6, 489–498.

    Article  CAS  Google Scholar 

  110. Brett, S. J., Payne, S. N., Gigg, I., Burgess, P., and Gigg, R. (1986) Use of synthetic glycoconjugates containing the Mycobacterium leprae specific and immunodominant epitope of phenolic glycolipid I in the serology of leprosy. Clin. Exp. Immunol. 64, 476–483.

    PubMed  CAS  Google Scholar 

  111. Pozsgay, V. (1998) Synthesis of glycoconjugate vaccines against Shigella dysenteriae type 1. J. Org. Chem. 63, 5983–5999.

    Article  PubMed  CAS  Google Scholar 

  112. Nashed, M. A. (1983) Glycosidic derivatives of 2-acetamido-2-deoxy-D-galactopyranose suitable for use as ligands in affinity chromatography. Carbohydr. Res. 123, 241–246.

    Article  CAS  Google Scholar 

  113. Ekborg, G., Eklind, K., Garegg, P. J., Gotthammar, B., Carlsson, H. E., Lindberg, A. A., et al. (1977) Artificial disaccharide-protein conjugates as immunogens for the preparation of specific anti-Salmonella O-antisera. Immunochemistry 14, 153–157.

    Article  PubMed  CAS  Google Scholar 

  114. Roy, R., Andersson, F. O., Harms, G., Kelm, S., and Schauer, R. (1992) Synthesis of esterase-resistant 9-0-acetylated polysialoside as inhibitor of influenza C virus haemag-glutinin. Angew. Chem. Int. Ed. Eng. 31, 1478–1481.

    Article  Google Scholar 

  115. Bock, K. and Meldal, M. (1984) Synthesis of the branchpoint tetrasaccharide of the O-specific determinant of Salmonella serogroup B. Acta Chem. Scand. B. 38, 71–77.

    Article  Google Scholar 

  116. Lee, H.-H., Schwartz, D. A., Harris, J. F., Carver, J. P., and Krepinsky, J. J. (1986) Syntheses of model oligosaccharides of biological significance. 7. Synthesis of a fucosylated N,N 1-diacetylchitobioside linked to bovine serum albumin and immunochemical characterization of rabbit antisera to this structure. Can. J. Chem. 64, 1912–1918.

    Article  CAS  Google Scholar 

  117. Tahir, S. H. and Hindsgaul, O. (1986) Substrates for the differentiation of the N-acetylglucosaminyltransferases. Synthesis of βDGlcNAc-(1,2)-αDMan-(1,6)-βDMan and βDGLcNAc-(1,2)-αDMan-(1,6)-[αLDMan-(1,3)]-βDMan glycosides. Can. J. Chem. 64, 1771–1780.

    Article  CAS  Google Scholar 

  118. Boons, G. J. P. H., van der Marel, G. A., Poolman, J. T., and van Boom, J. H. (1989) Synthesis of L-glycero-α-D-manno-heptopyranose-containing disaccharide derivatives of the Nesseria meningitidis dephosphorylated inner-core region. Recl. Trav. Chim. Pays-Bas. 108, 339–343.

    Article  CAS  Google Scholar 

  119. Veeneman, G. H., Notermans, S., Hoogerhout, P., and van Boom, J. H. (1989) Synthesis of an immunologically active component of the extra cellular polysaccharide produced by Aspergillus and Penicillium species. Recl. Trav. Chim. Pays-Bas. 108, 344–350.

    Article  CAS  Google Scholar 

  120. Veeneman, G. H., Brugghe, H. F., Hoogerhout, P., van der Marel, G. A., and van Boom, J. H. (1988) Synthesis of a cell wall component of Haemophilus (Actinobacillus) pleuropneu-moniae type 2. Recl. Tray. Chim. Pays-Bas. 107, 610–612.

    Article  CAS  Google Scholar 

  121. Hoogerhout, P., Evenberg, D., van Boeckel, C. A. A., Poolman, J. T., Beuvery, E. C., van der Marel, G. A., et al. (1987) Synthesis of fragments of the capsular polysaccharide of Haemophilus influenzae type b, comprising two and three repeating units. Tetrahedron Lett. 28, 1553–1556.

    Article  CAS  Google Scholar 

  122. Hoogerhout, P., Funke, C. W., Mellema, J.-R., Wagenaars, G. N., van Boeckel, C. A. A., Evenberg, D., et al. (1988) Synthesis of fragments of the capsular polysaccharide of Haemophilus influenzae type b. Part II. Preparation and structural analysis of fragments comprising two and three repeating units. J. Carbohyd. Chem 7, 399–416; erratum, ibid. (1989) 8, 167.

    Article  CAS  Google Scholar 

  123. Evenberg, D., Hoogerhout, P., van Boeckel, C. A. A., Rijkers, G. T., Beuvery, E.C., van Boom, J. H., et al. (1992) Preparation, antigenicity, and immunogenicity of synthetic ribosylribitol phosphate oligomer-protein conjugates and their potential use for vaccination against Haemophilus influenzae type b disease. J. Infect. Dis. 165, S152–S155.

    PubMed  CAS  Google Scholar 

  124. Verheul, A. F. M., Boons, G. J. P. H., van der Marel, G. A., van Boom, J. H., Jennings, H. J., Snippe, H., et al. (1991) Minimal oligosaccharide structures required for induction of immune responses against meningococcal immunotype L1, L2, and L3,7,9 lipopolysac-charides determined by using synthetic oligosaccharide-protein conjugates. Infect. Immun. 59, 3566–3573.

    PubMed  CAS  Google Scholar 

  125. Boons, G. J. P. H., Hoogerhout, P., Poolman, J. T., van der Marel, G. A., and van Boom, J. H. (1991) Preparation of a well-defined sugar-peptide conjugate. A possible approach to a synthetic vaccine against Neisseria meningitidis. Bioorg. Medicinal. Chem. Lett. 1, 303–308.

    Article  CAS  Google Scholar 

  126. Dubois, M., Gilles, K. A., Hamilton, J. K., Rebers, P. A., and Smith, F. (1956) Calorimetric method for determination of sugars and related substances. Anal. Chem. 28, 350–356.

    Article  CAS  Google Scholar 

  127. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265–275.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory for Vaccine Development and Immune Mechanisms, National Institute of Public Health and Environmental Protection, Bilthoven, The Netherlands

    Carla C. A. M. Peeters, Patrick R. Lagerman, Odo de Weers, Lukas A. Oomen, Peter Hoogerhout & Michel Beurret

  2. GlaxoSmithKline Biologicals SA, Rixensart, Belgium

    Jan T. Poolman

  3. Health Protection Agency, Centre for Applied Microbiology and Research, Porton Down, Salisbury, UK

    Karen M. Reddin

Authors
  1. Carla C. A. M. Peeters
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patrick R. Lagerman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Odo de Weers
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lukas A. Oomen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Peter Hoogerhout
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Michel Beurret
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jan T. Poolman
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Karen M. Reddin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Centre for Applied Microbiology and Research, Health Protection Agency, Porton Down, Salisbury, Wiltshire, UK

    Andrew Robinson  & Michael J. Hudson  & 

  2. Department of Cellular and Molecular Medicine, St. George’s Hospital Medical School, London, UK

    Martin P. Cranage

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Humana Press Inc., Totowa, NJ

About this protocol

Cite this protocol

Peeters, C.C.A.M. et al. (2003). Preparation of Polysaccharide-Conjugate Vaccines. In: Robinson, A., Hudson, M.J., Cranage, M.P. (eds) Vaccine Protocols. Methods in Molecular Medicine™, vol 87. Humana Press. https://doi.org/10.1385/1-59259-399-2:153

Download citation

  • DOI: https://doi.org/10.1385/1-59259-399-2:153

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-140-0

  • Online ISBN: 978-1-59259-399-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation